11-22274548-CTTTTT-CTTTT
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_213599.3(ANO5):c.2236-10delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 1,076,456 control chromosomes in the GnomAD database, including 2,188 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.051 ( 227 hom., cov: 27)
Exomes 𝑓: 0.12 ( 1961 hom. )
Consequence
ANO5
NM_213599.3 intron
NM_213599.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.693
Publications
3 publications found
Genes affected
ANO5 (HGNC:27337): (anoctamin 5) This gene encodes a member of the anoctamin family of transmembrane proteins. The encoded protein is likely a calcium activated chloride channel. Mutations in this gene have been associated with gnathodiaphyseal dysplasia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
ANO5 Gene-Disease associations (from GenCC):
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- gnathodiaphyseal dysplasiaInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive limb-girdle muscular dystrophy type 2LInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- Miyoshi muscular dystrophy 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 11-22274548-CT-C is Benign according to our data. Variant chr11-22274548-CT-C is described in ClinVar as [Benign]. Clinvar id is 1174994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0649 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0515 AC: 7563AN: 146856Hom.: 227 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
7563
AN:
146856
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.145 AC: 16715AN: 115060 AF XY: 0.148 show subpopulations
GnomAD2 exomes
AF:
AC:
16715
AN:
115060
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.124 AC: 115698AN: 929528Hom.: 1961 Cov.: 0 AF XY: 0.124 AC XY: 57040AN XY: 459084 show subpopulations
GnomAD4 exome
AF:
AC:
115698
AN:
929528
Hom.:
Cov.:
0
AF XY:
AC XY:
57040
AN XY:
459084
show subpopulations
African (AFR)
AF:
AC:
1404
AN:
22074
American (AMR)
AF:
AC:
1972
AN:
22580
Ashkenazi Jewish (ASJ)
AF:
AC:
1461
AN:
14414
East Asian (EAS)
AF:
AC:
1280
AN:
19516
South Asian (SAS)
AF:
AC:
5414
AN:
52572
European-Finnish (FIN)
AF:
AC:
5909
AN:
34920
Middle Eastern (MID)
AF:
AC:
304
AN:
4090
European-Non Finnish (NFE)
AF:
AC:
93396
AN:
721770
Other (OTH)
AF:
AC:
4558
AN:
37592
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.428
Heterozygous variant carriers
0
5300
10600
15900
21200
26500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0515 AC: 7561AN: 146928Hom.: 227 Cov.: 27 AF XY: 0.0515 AC XY: 3684AN XY: 71574 show subpopulations
GnomAD4 genome
AF:
AC:
7561
AN:
146928
Hom.:
Cov.:
27
AF XY:
AC XY:
3684
AN XY:
71574
show subpopulations
African (AFR)
AF:
AC:
1205
AN:
40376
American (AMR)
AF:
AC:
454
AN:
14636
Ashkenazi Jewish (ASJ)
AF:
AC:
109
AN:
3364
East Asian (EAS)
AF:
AC:
2
AN:
5048
South Asian (SAS)
AF:
AC:
105
AN:
4630
European-Finnish (FIN)
AF:
AC:
1009
AN:
9482
Middle Eastern (MID)
AF:
AC:
11
AN:
286
European-Non Finnish (NFE)
AF:
AC:
4407
AN:
66194
Other (OTH)
AF:
AC:
83
AN:
2012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
348
696
1043
1391
1739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Nov 03, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Miyoshi muscular dystrophy 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gnathodiaphyseal dysplasia Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gnathodiaphyseal dysplasia;C1969785:Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Autosomal recessive limb-girdle muscular dystrophy type 2L Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.